Daunomycinone is the aglycone metabolite of daunorubicin, an anthracycline antibiotic used in chemotherapy for the treatment of acute leukemias and lymphomas. As a key degradation product, its characterization… Read more
Daunomycinone is the aglycone metabolite of daunorubicin, an anthracycline antibiotic used in chemotherapy for the treatment of acute leukemias and lymphomas. As a key degradation product, its characterization is vital for pharmaceutical analysis and regulatory compliance. This category provides essential reference standards, including pharmacopeial and non-pharmacopeial impurities, required for rigorous impurity profiling and method validation. Furthermore, the inclusion of stable isotope labelled compounds, such as deuterated and carbon-13 variants, enables laboratories to employ these materials as internal standards during mass spectrometry analysis. These compounds are critical for the accurate quantification of drug levels in biological matrices and for assessing metabolic stability throughout the pharmaceutical development cycle. Access to these specialized compounds ensures that researchers and analytical laboratories can maintain high-quality testing protocols and consistent data during the assessment of oncology therapeutics.